Insights On Pharmaceutical Production

  1. Rapid A BioSMB Biolayer Interferometry Technology 4/14/2025

    Monoclonal antibodies are crucial for treating severe diseases. Explore dynamic loading in continuous multi-column chromatography and the growing market due to high specificity and fewer side effects.

  2. Applying Automation To The Manufacture Of Drug Delivery Devices 7/12/2023

    Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

  3. Innovative Octet® Biolayer Interferometry (BLI) Approach For Non-Disruptive And Fast AAV Capsid Ratio Determination In Complex Biological Matrices 9/27/2024

    Learn about a biosensor that was designed to provide the rapid, real-time, high-throughput measurement of AAV capsid titer in samples throughout the AAV workflow.

  4. Alkaline Stability Of Modern Protein A Chromatography Resins 7/12/2023

    Explore results from a resin lifetime study with over 150 cycles, using clarified cell harvest in every cycle, which has been performed to evaluate the alkaline stability of three protein A resins.

  5. Transitioning Your Product From Phase 1 To Phase 2 Clinical Studies 12/13/2024

    Strategic partnerships can streamline your transition from Phase 1 to Phase 2 clinical studies, ensuring optimized dosage forms, seamless scale-up, and alignment with patient and study requirements.

  6. Scale-Up Approaches For Culturing Adherent Cells 3/5/2025

    For successful scale-up, see how optimizing process parameters such as attachment methods, gassing, and agitation can help reduce cell environmental stress, ultimately improving productivity.

  7. Three Steps To Digital Transformation In Life Sciences Manufacturing 1/30/2025

    Explore trends that are transforming the industry, some common speedbumps on the road to innovation, and how a new platform offers unprecedented process transparency and continuous improvement.

  8. Modified Release Formulations: Extending Drug Commercial Lifecycle 3/1/2024

    A CDMO with expertise in modified-release dosage forms can provide valuable assistance in formulation development, processing considerations, analytical challenges, and regulatory requirements.

  9. Cost Effective 2D Rocking Motion Bioreactors For Perfusion Processes 4/14/2025

    Discover how modern technology platforms, like 2D rocking motion bioreactors, intensify bio-manufacturing processes to drive seed ratios, reduce costs, and shorten production times in biopharma.

  10. Optimizing Human iPSC Aggregate And Organoid Production For Bioprinting 4/17/2024

    This study aimed to identify the optimal cell culture conditions to yield high cell density and maintain high cell viability with consistent aggregate morphology and pluripotency marker expression.